Skip to main content

Table 1 Changes in glycemic control and body weight with acarbose treatment

From: Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report

Variable Pre-treatment Post-treatment Mean changes from baseline (95%CI) p-value
GHbA1c (%) 7.00 ± 0.74 6.18 ± 0.51 -0.82(-1.23, -0.41) 0.000
FPG (mmol/L) 8.31 ± 0.93 7.20 ± 0.85 -1.11(-1.56, -0.66) 0.000
P2PG (mmol/L) 14.34 ± 2.65 10.10 ± 1.12 -4.25(-5.56, -2.94) 0.000
Weight (kg) 74.71 ± 12.30 74.96 ± 11.70 -0.25(-0.78, 0.28) 0.341
BMI (kg/m2) 26.64 ± 3.38 26.64 ± 0.38 -0.10(-0.29, 0.09) 0.279
  1. Data are expressed as mean ± S.D; HbA1c: glycated haemoglobin A1c; FPG: fasting plasma glucose; P2PG: 2 hour postprandial plasma glucose; BMI: body mass index.